About us For the last decade, Blockchain Labs (BCL) has been developing blockchain-based infrastructure, that operates without cryptocurrency, to offer groundbreaking security and scalability for sensitive and proprietary data. Our globally patented technology, InfraBlockchainⓅ, enables secure, transparent, and cost-effective applications for a variety of industries. In 2020, BCL developed the COOV app, the world’s first blockchain-based vaccine pass, accepted in 120+ countries globally, and used by over 43 million people, 30+ million times a day. Following a$30 million Series A in 2022, BCL embarked on its most ambitious project to date, Newnal (“New Era” in Korean). Newnal offers unprecedented precision and privacy in generative AI by ensuring the utmost integrity, security, and reliability of sensitive data. Newnal redefines how data is handled – transforming the landscape of B2B and B2C AI applications where trust and accuracy are non-negotiable. For more information, visit bc-labs.net/en